icon-folder.gif   Conference Reports for NATAP  
 
  5th IAS Conference on HIV Pathogenesis, Treatment and Prevention
July 19th-22nd 2009
Capetown, South Africa
Back grey_arrow_rt.gif
 
 
 
Similar Declines in HIV-1 RNA (Viral load, VL) from Baseline (BL) to 96 Weeks Observed in Subjects Randomized to ABC/3TC or TDF/FTC each with Lopinavir/Ritonavir (LPV/r) in the HEAT Trial (EPZ104057)
 
 
  Reported by Jules Levin
5th IAS Capetown July 19-22 2009
 
Linda Yau1, Jaime Hernandez2, Parul Patel1, Lynn Dix1, Keith Pappa1, and Mark Shaefer1 1GlaxoSmithKline Research and Development, Research Triangle Park, North Carolina, USA; 2BioCryst Pharmaceuticals, Inc., Cary, North Carolina, USA.

image002.gif

image004.gif

image006.gif

image008.gif

image010.gif

image012.gif

image014.gif

image016.gif

image018.gif

image020.gif

image022.gif